UNSPSC 51191928: Acetylcarnitine

This classification denotes a nutritional supplement, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DH1W9VH8Q. European Medicines Agency schedules Acetylcarnitine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12716MIG. Acetylcarnitine generally arises in the molecular formula C8H16CLNO4. The term 'acetylcarnitine' is a Hazardous Substances Data Bank designation. As of Q4 2014, ACETYLCARNITINE remains the US FDA Preferred Term for this commodity.

Acetylcarnitine bears US NLM identifiers UMLS ID C0001040 and NCI Concept Code C87329. SMILES: O(C(C[N](C)(C)C)CC(=O)O)C(=O)C.

UNSPSC 51191928 Acetylcarnitine is a Commodity code that appears to classify pharmaceutical and chemical products used in state and local government operations, though recent solicitations tagged under this code diverge substantially from the acetylcarnitine specification. The City of Meriden, Connecticut, solicited bids for sodium bisulfite chemical supply for municipal water treatment operations under IFB B027-15, due July 29, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP for generic multi-source pharmaceuticals and over-the-counter products to serve state and local government facilities across participating jurisdictions including Oregon, with proposals due March 26, 2026. State and local buyers under this code span municipal utilities, state procurement offices, and cooperative purchasing alliances that aggregate demand across multiple member jurisdictions. The scope reflects actual purchasing of chemical commodities for infrastructure operations and pharmaceutical products for healthcare or institutional use distributed through established wholesaler networks, not acetylcarnitine specifically.

Activity under this code concentrates in the upper Midwest and Connecticut. The MMCAP cooperative vehicle represents a multi-state purchasing mechanism serving participating state and local agencies across Oregon and Minnesota, with awarded vendors required to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson) by July 1, 2026. Vendors responding to MMCAP must certify cGMP and DSCSA compliance, maintain contractual relationships with at least two of the three authorized wholesalers, and accept a 3 percent administrative fee; evaluation weights 75 percent on price competitiveness and 25 percent split across compliance, pricing format, and EDI capability. The Meriden solicitation requires performance and payment bonds and General Liability coverage of $1,000,000 to $2,000,000 with Connecticut-approved carriers. The code shows limited recent activity and a mismatch between its nominal scope (acetylcarnitine) and the chemical and pharmaceutical products actually being bought through these mechanisms.